Cargando…

Discovery and Structure-Based Optimization of 6-Bromotryptamine Derivatives as Potential 5-HT(2A) Receptor Antagonists

5-Hydroxytryptamine type 2A (5-HT(2A)) receptor is an important target for developing innovative antipsychotic agents in neuropsychiatric disorder therapies. To search for 5-HT(2A) receptor antagonists, a new indole alkaloid termed 6-bromo-N-propionyltryptamine (1), together with one known homologue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Lijian, He, Shan, Wu, Wei, Jin, Haixiao, Zhu, Peng, Zhang, Jinrong, Wang, Tingting, Yuan, Ye, Yan, Xiaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331983/ https://www.ncbi.nlm.nih.gov/pubmed/26404234 http://dx.doi.org/10.3390/molecules200917675

Ejemplares similares

Bromotryptamine and Bromotyramine Derivatives from the Tropical Southwestern Pacific Sponge Narrabeena nigra
por: Miguel-Gordo, Maria, et al.
Publicado: (2019)

Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats
por: Fijał, Katarzyna, et al.
Publicado: (2013)

Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT(3) and 5-HT(6) Receptor Antagonist with Antipsychotic and Procognitive Properties
por: Zajdel, Paweł, et al.
Publicado: (2021)

Distribution of cells responsive to 5-HT(6) receptor antagonist-induced hypophagia
por: Garfield, Alastair S., et al.
Publicado: (2014)

Azologization of serotonin 5-HT(3) receptor antagonists
por: Rustler, Karin, et al.
Publicado: (2019)

The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT(3) receptors
por: Lochner, Martin, et al.
Publicado: (2016)

Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, HEC30654, in Healthy Chinese Subjects
por: Li, Xiaojiao, et al.
Publicado: (2021)

Extended N-Arylsulfonylindoles as 5-HT(6) Receptor Antagonists: Design, Synthesis & Biological Evaluation
por: Vera, Gonzalo, et al.
Publicado: (2016)

Dual 5-HT(3) and 5-HT(6) Receptor Antagonist FPPQ Normalizes Phencyclidine-Induced Disruption of Brain Oscillatory Activity in Rats
por: Castañé, Anna, et al.
Publicado: (2022)

Molecular Networking-Driven Discovery of Antibacterial Perinadines, New Tetracyclic Alkaloids from the Marine Sponge-Derived Fungus Aspergillus sp.
por: Liu, Yang, et al.
Publicado: (2022)

In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
por: Bojić, Tijana, et al.
Publicado: (2022)

Preparative Isolation and Purification of Lignans from Justicia procumbens Using High-Speed Counter-Current Chromatography in Stepwise Elution Mode
por: Zhou, Peijuan, et al.
Publicado: (2015)

5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress
por: Andrews, Megan, et al.
Publicado: (2018)

The 5-HT(2C) receptor agonist, lorcaserin, and the 5-HT(6) receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour
por: Higgs, Suzanne, et al.
Publicado: (2015)

Role of 5-HT(2A) receptor antagonists in the treatment of insomnia
por: Vanover, Kimberly E, et al.
Publicado: (2010)

Effects of 5‐HT(₃) receptor antagonists on cisplatin‐induced kidney injury
por: Goda, Mitsuhiro, et al.
Publicado: (2021)

New Triazine Derivatives as Serotonin 5-HT(6) Receptor Ligands
por: Łażewska, Dorota, et al.
Publicado: (2023)

Superiority of the Triple-Acting 5-HT(6)R/5-HT(3)R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT(6)R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats
por: Grychowska, Katarzyna, et al.
Publicado: (2023)

CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
por: Capi, Matilde, et al.
Publicado: (2021)

Discovery, Optimization, and Characterization of Novel D(2) Dopamine Receptor Selective Antagonists
por: Xiao, Jingbo, et al.
Publicado: (2014)

Constitutively Active 5-HT Receptors: An Explanation of How 5-HT Antagonists Inhibit Gut Motility in Species Where 5-HT is Not an Enteric Neurotransmitter?
por: Spencer, Nick J.
Publicado: (2015)

Discovery of Novel Indolealkylpiperazine Derivatives as Potent 5-HT(1A) Receptor Agonists for the Potential Future Treatment of Depression
por: Zhu, Chen, et al.
Publicado: (2020)

Existence of Brain 5-HT1A–5-HT2A Isoreceptor Complexes with Antagonistic Allosteric Receptor–Receptor Interactions Regulating 5-HT1A Receptor Recognition
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2017)

Recent advances in antiemetics: new formulations of 5HT(3)-receptor antagonists
por: Gilmore, James, et al.
Publicado: (2018)

Serotonin 5-HT3 Receptor Antagonist for Treatment of Severe Diabetic Diarrhea
por: Murao, Satoshi, et al.
Publicado: (2010)

Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013)

5-HT1A agonists, 5-HT3 antagonists and benzodiazepines : their comparative behavioural pharmacology /
Publicado: (1991)

5-HT3 receptor antagonists for the prevention of postoperative shivering: a meta-analysis
por: Zhou, Chengmao, et al.
Publicado: (2016)

5-HT(6 )receptors and Alzheimer's disease
por: Ramírez, María Javier
Publicado: (2013)

Discovery of novel polysubstituted N-alkyl acridone analogues as histone deacetylase isoform-selective inhibitors for cancer therapy
por: Wang, Ze, et al.
Publicado: (2023)

Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT(2A) Receptor Agonists
por: Poulie, Christian B. M., et al.
Publicado: (2022)

Antidepressant Potential of 5-HT(3) Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n)
por: Mahesh, R, et al.
Publicado: (2012)

The effect of the intramolecular C–H⋯O interactions on the conformational preferences of bis-arylsulfones – 5-HT(6) receptor antagonists and beyond
por: Kalinowska-Tłuścik, Justyna, et al.
Publicado: (2018)

Correction: Synthesis and evaluation of nuciferine and roemerine enantiomers as 5-HT(2) and α(1) receptor antagonists
por: Heng, Hui Li, et al.
Publicado: (2018)

Idalopirdine – a small molecule antagonist of 5-HT(6) with therapeutic potential against obesity
por: Dudek, Magdalena, et al.
Publicado: (2015)

Serotonin (5-HT(3)) receptor antagonists for the reduction of symptoms of low anterior resection syndrome
por: Itagaki, Ryohei, et al.
Publicado: (2014)

Nephrotoxicity Evaluation on Cisplatin Combined with 5-HT(3) Receptor Antagonists: A Retrospective Study
por: Kou, Wen, et al.
Publicado: (2018)

Anti-dyskinetic efficacy of 5-HT3 receptor antagonist in the hemi-parkinsonian rat model
por: Aboulghasemi, Nazanin, et al.
Publicado: (2018)

ADN-1184, a monoaminergic ligand with 5-HT(6/7) receptor antagonist action, exhibits activity in animal models of anxiety
por: Partyka, Anna, et al.
Publicado: (2016)

A new serotonin 5-HT(6) receptor antagonist with procognitive activity – Importance of a halogen bond interaction to stabilize the binding
por: González-Vera, Juan A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_87eaudvmt2hle0qg37mh4pivtj